April 27, 2017 Clinical Research/Diagn. Mass Spectrometry

BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering

Mass spectrometry identification solution may help hospitals manage antimicrobial resistance more effectively FRANKLIN LAKES, N.J., Apr. 27, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global distribution of a complete portfolio of products for mass spectrometry that provides high-speed and high-confidence identification of pathogens in... Read more

April 26, 2017 Life Science Tools

Seegene Unlocks the Door to the Next Level of the Real-time PCR Business

26 Apr, 2017, 09:00 ET SEOUL, South Korea, April 26, 2017 /PRNewswire/ — Seegene Inc. (096530.KQ), the leading developer of multiplex PCR technologies, announced that it is entering into more innovative and powerful business realm by developing the Second-generation Real-time PCR Technology which has been recently patented in the United States and Europe. Seegene’s Second-generation... Read more

April 26, 2017 Chromatography Informatics & Software M&A, Partnerships Mass Spectrometry

Integration with SCPA chromatography software

26 April 2017 Microsaic Systems plc (“Microsaic”, “Microsaic Systems” or the “Company”) Integration with SCPA chromatography software Microsaic Systems plc (AIM: MSYS), the developer of chip-based mass spectrometry instruments, is pleased to announce its collaboration with SCPA GmbH (“SCPA”), and the integration of Microsaic’s 4000 MiD® compact mass spectrometer with SCPA’s universal PrepCon 5 preparative... Read more

April 26, 2017 Licensing, IP, and Legal Life Science Tools

BD Licenses Novel Molecular Indexing Technology to Roche

FRANKLIN LAKES, N.J., Apr. 26, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has non-exclusively licensed its patented stochastic labelling technology to Roche for multiple commercial applications. BD’s patented stochastic labelling technology incorporating molecular indexes (known also as UMIs or molecular barcodes), enables the... Read more

April 26, 2017 Atomic Spectroscopy M&A, Partnerships

Sale of Industrial Analysis business to Hitachi High-Technologies

26 April 2017 This announcement includes inside information Oxford Instruments plc, a leading provider of high technology solutions, information and services for industry and research, today announces that it has agreed to sell its Industrial Analysis business to Hitachi High-Technologies Corporation (‘HHT’) for a consideration of £80 million on a cash and debt free basis.... Read more

April 26, 2017 PR/Corporate

Luminex Corporation To Present At The Deutsche Bank 42nd Annual Health Care Conference

AUSTIN, Texas, April 26, 2017 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) announced today that management will present at the Deutsche Bank 42nd Annual Health Care Conference on Wednesday, May 3, 2017 at 10:00am ET in Boston, Massachusetts. The investor presentation will be webcast live and may be accessed at Luminex Corporation’s website at http://www.luminexcorp.com. Simply log on to... Read more

April 26, 2017 PR/Corporate

Luminex Corporation To Present At The Deutsche Bank 42nd Annual Health Care Conference

AUSTIN, Texas, April 26, 2017 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) announced today that management will present at the Deutsche Bank 42nd Annual Health Care Conference on Wednesday, May 3, 2017 at 10:00am ET in Boston, Massachusetts. The investor presentation will be webcast live and may be accessed at Luminex Corporation’s website at http://www.luminexcorp.com. Simply log on to... Read more

April 26, 2017 Bio/Pharma/CRO Clinical Research/Diagn.

New data at AAN reinforce clinical benefit of Roche's OCREVUS™ (ocrelizumab) for relapsing and primary progressive multiple sclerosis

Basel, 26 April 2017 New data at AAN reinforce clinical benefit of Roche’s OCREVUS™ (ocrelizumab) for relapsing and primary progressive multiple sclerosis OCREVUS rapidly suppressed signs of disease activity in relapsing MS (RMS) patients In patients with early RMS – recently diagnosed and without prior treatment – OCREVUS was superior to Rebif® (interferon beta-1a) in... Read more

April 25, 2017 Clinical Research/Diagn. Environ, Ag./Food & Bev Forensics & Security PR/Corporate

Two Pore Guys Raises $24.5 Million in Series A Financing

Investment Led by Khosla Ventures with Eye on Developing an Industry for Diagnostics Based on the 2PG Platform April 25, 2017 04:30 AM Pacific Daylight Time SANTA CRUZ, Calif.–(BUSINESS WIRE)–Two Pore Guys, Inc. (2PG), today announced the close of a Series A venture financing round in the amount of $24.5 million, led by Khosla Ventures.... Read more